Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Notes Payables (2025 - 2026)

Updated

Analysis

Dianthus Therapeutics (DNTH) Notes Payables (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 105,456.00
Jun 30, 2026 68,417.00
Mar 31, 2026 36,895.00
Sep 30, 2025 8,077.00
API Access

Dianthus Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=DNTH&period=max&api_key=YOUR_API_KEY